What the Science Says: Clinical Evidence So Far Clinical research on peptide therapy for hair growth is still relatively new, but the early signs are promising
However, gut dysbiosis in PCOS is associated with a decline in SCFAs-producing and BA-metabolizing bacteria, leading to a shift toward pro-inflammatory microbial communities and a reduction in anti-inflammatory taxa (54, 55)
Disclaimer Retatrutide is an investigational research compound
This makes FOXO4-DRI a specialized peptide for advanced research models examining cellular aging, senescence-associated signaling, tissue remodeling, and programmed cell death pathway regulation
paired t test), as well as a trend for improvement in the categories of pressure pain and pain attacks ( p = 0.08 and p = 0.09) in the ARA 290 group, but not in the placebo group